Delivery Order SPE2DB20D1100-SPE2DB25FB9U2
Award Date
4/28/25
Potential Completion Date
4/29/25
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,370.10, is for the delivery of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device, with a completion date of April 22, 2025. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp is the prime contractor and holds a larger $999,999,999.00 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,938.43, is for the delivery of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device used in the treatment of diabetes. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 11, 2025. The contract is not set-aside and was awarded on April 10, 2025....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,618.58, is for the delivery of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device used for diabetes management. The contract has a firm fixed price pricing type and an ultimate completion date of February 20, 2025. This delivery order is part of a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,317.64, is for the delivery of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device used for diabetes management. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 17, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device, with a ceiling value of $3,801.01 and a period of performance through April 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business category. Amerisourcebergen Drug Corp is the prime...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,341.44, is for the delivery of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device, with a performance period ending on April 16, 2025. The contract is a firm fixed-price, non-set-aside arrangement. Amerisourcebergen Drug Corp is the prime contractor and holds a larger Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,064.47, is for the provision of OMNIPOD 5 DEXG7G6 INTRO(GEN 5)S medical devices. The award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device, with a ceiling value of $9,746.97 and a period of performance through April 16, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business type. Amerisourcebergen Drug Corp is the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,042.43, is for the delivery of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device used in the treatment of diabetes. The contract is a firm fixed-price, non-set-aside award with a period of performance ending on April 21, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,042.97 firm-fixed-price delivery order is for the procurement of OMNIPOD 5 DEXG7G6 PODS (GEN 5), a medical device, with a period of performance through April 29, 2025. The contract is not set aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...